A detailed history of Navellier & Associates Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Navellier & Associates Inc holds 17,177 shares of JNJ stock, worth $2.65 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
17,177
Previous 18,058 4.88%
Holding current value
$2.65 Million
Previous $2.64 Million 5.46%
% of portfolio
0.39%
Previous 0.31%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$145.48 - $167.38 $128,167 - $147,461
-881 Reduced 4.88%
17,177 $2.78 Million
Q2 2024

Aug 08, 2024

SELL
$144.38 - $157.78 $14,438 - $15,778
-100 Reduced 0.55%
18,058 $2.64 Million
Q4 2023

Feb 08, 2024

BUY
$145.6 - $158.88 $126,235 - $137,748
867 Added 5.01%
18,158 $2.85 Million
Q3 2023

Nov 09, 2023

BUY
$155.75 - $174.48 $2.43 Million - $2.72 Million
15,591 Added 917.12%
17,291 $2.69 Million
Q2 2023

Aug 07, 2023

BUY
$154.35 - $166.11 $30,870 - $33,222
200 Added 13.33%
1,700 $281,000
Q1 2023

May 12, 2023

SELL
$151.05 - $180.26 $15,105 - $18,026
-100 Reduced 6.25%
1,500 $232,000
Q4 2022

Feb 02, 2023

BUY
$160.2 - $179.79 $16,019 - $17,979
100 Added 6.67%
1,600 $282,000
Q3 2022

Nov 09, 2022

SELL
$161.33 - $179.52 $32,266 - $35,904
-200 Reduced 11.76%
1,500 $245,000
Q1 2022

Apr 29, 2022

SELL
$158.14 - $179.59 $15,813 - $17,959
-100 Reduced 5.56%
1,700 $301,000
Q4 2021

Feb 14, 2022

SELL
$155.93 - $173.01 $15,593 - $17,301
-100 Reduced 5.26%
1,800 $308,000
Q2 2021

Aug 09, 2021

BUY
$159.48 - $171.07 $15,947 - $17,107
100 Added 5.56%
1,900 $313,000
Q1 2021

May 12, 2021

SELL
$153.07 - $170.48 $37,042 - $41,256
-242 Reduced 11.85%
1,800 $296,000
Q1 2020

May 13, 2020

SELL
$111.14 - $153.99 $44,456 - $61,596
-400 Reduced 16.38%
2,042 $268,000
Q4 2019

Feb 12, 2020

BUY
$127.5 - $146.44 $38,250 - $43,932
300 Added 14.01%
2,442 $356,000
Q3 2019

Oct 16, 2019

BUY
$126.95 - $142.14 $25,390 - $28,427
200 Added 10.3%
2,142 $277,000
Q2 2019

Jul 17, 2019

BUY
$131.15 - $144.24 $13,115 - $14,424
100 Added 5.43%
1,942 $270,000
Q1 2019

May 15, 2019

BUY
$125.72 - $139.79 $12,572 - $13,979
100 Added 5.74%
1,842 $257,000
Q4 2018

Jan 15, 2019

SELL
$122.84 - $147.84 $12,284 - $14,784
-100 Reduced 5.43%
1,742 $225,000
Q3 2018

Nov 14, 2018

SELL
$121.58 - $142.88 $69,908 - $82,156
-575 Reduced 23.79%
1,842 $255,000
Q2 2018

Aug 06, 2018

SELL
$119.4 - $131.76 $18,865 - $20,818
-158 Reduced 6.14%
2,417 $293,000
Q1 2018

May 21, 2018

SELL
$125.1 - $148.14 $235,188 - $278,503
-1,880 Reduced 42.2%
2,575 $330,000
Q4 2017

Feb 12, 2018

SELL
$131.22 - $143.62 $707,013 - $773,824
-5,388 Reduced 54.74%
4,455 $623,000
Q3 2017

Nov 14, 2017

SELL
$129.47 - $135.38 $462,596 - $483,712
-3,573 Reduced 26.63%
9,843 $1.28 Million
Q2 2017

Aug 24, 2017

BUY
N/A
13,416
13,416 $1.78 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $404B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Navellier & Associates Inc Portfolio

Follow Navellier & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Navellier & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Navellier & Associates Inc with notifications on news.